Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,209.00    19.00 (0.87%)
Bid:
2,212.00
Ask:
2,214.00
Spread: 2.00 (0.09%)
Market Cap: £22.41b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Director Declaration

6 Apr 2017 10:47

RNS Number : 8080B
3i Group PLC
06 April 2017
Β 

Β 

3i Group plc: Director declaration

Β 

Stephen Daintith

Β 

Further to 3i Group plc's announcement on 22 September 2016 (RNS 5628K) that Stephen Daintith, a non-executive Director of 3i Group plc, had been appointed as Chief Financial Officer and an executive director of Rolls-Royce Holdings plc with effect from a date in early 2017 to be notified in due course, 3i Group plc has now been notified that Mr Daintith's appointment at Rolls-Royce Holdings plc will take effect on 7 April 2017.

Β 

This announcement is made pursuant to paragraph 9.6.14R of the UKLA's Listing Rules.

Β 

Β 

-Ends-

Β 

For further information, contact:

Kathryn van der Kroft 020 7975 3021

Communications Director

Β 

Silvia Santoro 020 7975 3258

Investor Relations Director

Β 

Notes to Editors:

Β 

About 3i Group

Β 

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDNOKADQCBKKPQK
Date   Source Headline
31st Jan 20254:03 pmRNSTotal Voting Rights
31st Jan 20259:36 amRNSDirector Declaration
30th Jan 20257:00 amRNS3i Group plc - Q3 performance update
6th Jan 20253:40 pmRNSDirector/PDMR Shareholding
3rd Jan 20254:38 pmRNSTotal Voting Rights
2nd Jan 202510:59 amRNSPortfolio Update
10th Dec 202411:21 amRNSBlock listing Interim Review
29th Nov 20243:50 pmRNSTotal Voting Rights
29th Nov 20243:43 pmRNSDirector/PDMR Shareholding
14th Nov 202410:39 amRNSDoc re. Half Yearly Report 2024
14th Nov 20247:00 amRNSResults for the six months to 30 September 2024
1st Nov 20249:17 amRNSDirector/PDMR Shareholding
31st Oct 20243:43 pmRNSTotal Voting Rights
1st Oct 202410:09 amRNSPortfolio Update
30th Sep 20243:45 pmRNSTotal Voting Rights
30th Sep 20243:45 pmRNSDirector/PDMR Shareholding
30th Sep 202410:41 amRNSDirector/PDMR Shareholding
25th Sep 20249:36 amRNSDirector/PDMR Shareholding
24th Sep 20243:05 pmRNSDirector/PDMR Shareholding
24th Sep 20243:02 pmRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSUpdate on portfolio and Capital Markets Seminar
2nd Sep 202412:34 pmRNSDirector/PDMR Shareholding
30th Aug 20244:19 pmRNSTotal Voting Rights
1st Aug 202411:53 amRNSDirector/PDMR Shareholding
1st Aug 202411:37 amRNSDirector/PDMR Shareholding
31st Jul 20244:14 pmRNSTotal Voting Rights
22nd Jul 20243:37 pmRNSHolding(s) in Company
19th Jul 20242:22 pmRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNS3i Group plc FY2025 Q1 performance update
1st Jul 20249:54 amRNSPortfolio Update
28th Jun 20243:01 pmRNSTotal Voting Rights
28th Jun 20242:25 pmRNSDirector/PDMR Shareholding
28th Jun 20241:47 pmRNSDirector/PDMR Shareholding
28th Jun 20248:06 amRNSDirector/PDMR Shareholding
27th Jun 20243:34 pmRNSDirector/PDMR Shareholding
27th Jun 20243:05 pmRNSDoc re. AGM Resolutions
27th Jun 20243:04 pmRNSResult of AGM
27th Jun 20242:23 pmRNSHolding(s) in Company
27th Jun 20247:00 amRNSAGM and portfolio update
25th Jun 20249:27 amRNSHolding(s) in Company
21st Jun 20241:55 pmRNSHolding(s) in Company
7th Jun 202411:17 amRNSBlock listing Interim Review
5th Jun 20246:01 pmRNSDirector/PDMR Shareholding
4th Jun 20249:19 amRNSDirector/PDMR Shareholding
3rd Jun 202412:42 pmRNSDirector/PDMR Shareholding
31st May 20244:58 pmRNSTotal Voting Rights
31st May 20244:57 pmRNSDirector/PDMR Shareholding
31st May 20244:55 pmRNSDirector/PDMR Shareholding
22nd May 20243:32 pmRNSDoc Re: 2024 Notice of AGM
16th May 20243:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.